structur
studi
show
receptor
bind
domain
rbd
protein
highli
flexibl
present
two
conform
one
expos
predict
bind
host
cell
receptor
bind
receptor
two
proteolyt
event
requir
prior
fusion
viral
host
cell
membran
result
cell
entri
protein
princip
target
neutral
antibodi
respons
neutral
antibodi
block
entri
trigger
prematur
matur
subsequ
inactiv
protein
addit
protein
exhibit
low
affin
bind
glycan
import
infect
may
function
juxtapos
cellular
viral
membran
prior
receptor
bind
first
two
third
genom
rna
encod
larg
polyprotein
cleav
individu
protein
mani
requir
replic
transcript
three
nonstructur
protein
induc
membran
rearrang
includ
doubl
membran
vesicl
dmv
facilit
format
replicationtranscript
complex
rtc
rna
synthesi
actual
occur
nonstructur
protein
nsp
inhibit
host
gene
express
inhibit
host
mrna
translat
induc
degrad
host
mrna
inhibit
ifni
induct
serv
target
antivir
therapi
develop
figur
main
manuscript
rtc
format
use
host
cell
machineri
involv
vesicular
transport
misfold
protein
rna
transcript
occur
subgenom
mrna
cotermin
nest
henc
name
nidoviru
contain
common
leader
sequenc
deriv
genom
rna
subgenom
rna
encod
structur
protein
found
cov
accessori
protein
immuneevas
perhap
function
accessori
protein
uniqu
cov
rare
except
share
homolog
viral
host
protein
merscov
encod
accessori
protein
orf
embed
within
n
gene
accessori
protein
shown
interfer
ifn
induct
signal
nfkb
signal
although
mani
observ
made
use
protein
express
absenc
viru
infect
orf
variabl
delet
camel
human
isol
merscov
without
clear
chang
virul
result
togeth
support
essenti
role
accessori
protein
human
camel
merscov
infect
rather
rais
possibl
function
import
viru
virul
specif
host
set
mark
contrast
mutat
merscov
detect
human
isol
sinc
rare
except
fix
viral
genom
rather
chang
human
isol
appear
reflect
transmiss
variant
first
detect
camel
popul
remark
merscov
isol
reduc
affin
human
receptor
detect
korean
mer
outbreak
progress
unexpect
increas
receptor
affin
predict
emerg
enhanc
virul
occur
sar
epidem
affin
host
cell
receptor
angiotensinconvert
enzym
increas
time
viru
decreas
affin
receptor
appear
equival
parent
strain
virul
transmiss
suggest
factor
receptor
bind
suscept
proteas
requir
protein
process
rel
import
merscov
cellular
entri
epidemiolog
merscov
circul
dromedari
camel
popul
africa
arabian
peninsula
least
sever
decad
emerg
merscov
novel
human
pathogen
estim
merscov
identifi
dromedari
camel
sever
countri
across
africa
middl
east
south
asia
figur
much
lesser
extent
sheep
seneg
tunisia
egypt
serolog
evid
merscov
dromedari
found
countri
molecular
evid
merscov
circul
countri
experiment
infect
shown
infect
dromedari
shed
merscov
nasal
secret
minim
sign
ill
limit
rhinorrhea
half
primari
human
merscov
case
report
histori
exposur
dromedari
camel
one
third
commun
mer
case
report
contact
camel
although
dromedari
camel
import
sourc
merscovmedi
human
infect
diseas
exact
mode
transmiss
well
understood
sinc
approxim
half
primari
mer
case
report
histori
camel
exposur
figur
limit
humantohuman
transmiss
well
document
household
commun
hospit
outbreak
sever
experiment
infect
anim
model
mer
develop
although
recogn
none
anim
develop
protract
viru
replic
patholog
outcom
observ
human
nonhuman
primat
rabbit
dromedari
camel
infect
merscov
possibl
except
marmoset
anim
develop
mild
pneumonia
case
camel
rhiniti
chest
xray
exampl
chestxray
find
mer
patient
progress
cours
ill
shown
figur
intens
clinic
morbid
may
correl
imag
abnorm
radiograph
progress
unilater
focal
airspac
opac
either
multifoc
bilater
involv
second
phase
diseas
follow
radiograph
improv
treatment
commonli
observ
score
system
chest
xray
develop
korean
mer
outbreak
indic
mer
patient
radiograph
score
day
viral
exposur
may
requir
aggress
intens
therapi
care
surveil
followup
evalu
ct
scan
earli
phase
diseas
lung
parenchym
abnorm
typic
locat
peripher
lower
lobe
eventu
spread
entir
bilater
lung
advanc
stage
figur
whilst
ct
sensit
specif
chest
radiographi
high
rate
underli
comorbid
patient
merscov
may
creat
consider
difficulti
detect
diseas
progress
due
overlap
preexist
comorbid
lung
fibrosi
emphysema
infecti
complic
prevent
transmiss
merscov
commun
healthcar
set
critic
prevent
outbreak
spread
sever
substant
review
guidelin
avail
subject
effort
reduc
risk
transmiss
merscov
human
focu
potenti
role
camel
market
camel
race
import
transport
graze
amplif
shed
viru
provid
basi
evidencebas
control
approach
earli
identif
isol
suspect
confirm
case
ongo
surveil
key
prevent
nosocomi
spread
mutat
protein
essenti
virul
viru
replic
exampl
viru
mutat
requir
genom
fidel
replic
well
highli
attenu
mani
vaccin
test
anim
experiment
infect
merscov
includ
mice
express
receptor
nonhuman
primat
sever
current
undergo
phase
trial
safeti
immunogen
examin
healthi
adult
one
instanc
healthi
adult
age
year
vaccin
three
time
dna
vaccin
express
fulllength
consensu
merscov
protein
immunoconvers
measur
neutral
antibodi
cell
respons
subject
respect
although
declin
week
immun
vaccin
well
toler
mild
advers
effect
advers
effect
associ
dna
vaccin
deliv
im
electropor
partli
amelior
intraderm
deliveri
studi
immunogen
progress
encourag
result
need
advanc
quickli
phase
trial
adequ
number
subject
includ
elderli
comorbid
popul
evalu
effect
protect
long
last
immun
respons
mitig
futur
outbreak
allevi
diseas
burden
vulner
popul
elderli
immunosuppress
healthcar
worker
approach
camel
immun
protein
subunit
vaccin
onehealth
approach
tackl
mer
one
health
concept
focus
relationship
interconnected
human
anim
environ
recogn
health
wellb
human
intim
chest
xray
show
bilater
fine
reticulonodular
air
space
opac
